Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02661009
What this trial is testing

Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)

Who this might be right for
Non Small Cell Lung CancerEGFR-TKI Resistant MutationEGFR-TKI Sensitizing Mutation
GenoSaber 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06348134
What this trial is testing

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastHER2-positive Breast CancerBreast Cancer
University of Chicago 74
Early research (Phase 1)Study completedNCT00070616
What this trial is testing

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

Who this might be right for
LeukemiaLymphomaMyeloma
Swedish Orphan Biovitrum 25
Large-scale testing (Phase 3)Ended earlyNCT01996098
What this trial is testing

Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR Mutation

Who this might be right for
Lung Cancer
Sun Yat-sen University 251
Not applicableStudy completedNCT03171506
What this trial is testing

Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification

Who this might be right for
Ovarian CancerEndometrial Cancer
University of Alabama at Birmingham 57
Testing effectiveness (Phase 2)Ended earlyNCT00445549
What this trial is testing

Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT02829333
What this trial is testing

The Effect of Anesthetic Technique on VEGF-C and PGE2

Who this might be right for
Uterine Leiomyomas
General Hospital of Ningxia Medical University 44
Not applicableStudy completedNCT01818947
What this trial is testing

Gefitinib Usage and Outcomes in Routine Treatment

Who this might be right for
Lung Cancer
AstraZeneca 157
Not applicableNo Longer AvailableNCT00655252
What this trial is testing

Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

Who this might be right for
Metastatic Renal Cell Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT01526928
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer
Clovis Oncology, Inc. 612
Not applicableActive Not RecruitingNCT07750444
What this trial is testing

Underweight, Overweight, and Linear Growth of Childhood Cancer Patients - the Growth Study

Who this might be right for
Childhood Cancer
Fabiën Belle 12,150
Early research (Phase 1)Study completedNCT01475006
What this trial is testing

AMG 595 First-in-Human in Recurrent Gliomas

Who this might be right for
Advanced Malignant GliomaAnaplastic AstrocytomasGlioblastoma Multiforme
Amgen 32
Not applicableLooking for participantsNCT00001975
What this trial is testing

Study of Skin Tumors in Tuberous Sclerosis

Who this might be right for
Tuberous Sclerosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Testing effectiveness (Phase 2)UnknownNCT02934828
What this trial is testing

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 230
Early research (Phase 1)Study completedNCT02406521
What this trial is testing

Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets

Who this might be right for
Metastatic Renal Cell Carcinoma
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT03888092
What this trial is testing

Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sunshine Lake Pharma Co., Ltd. 81
Early research (Phase 1)Study completedNCT01703481
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

Who this might be right for
Tumor or Lymphoma
Janssen Research & Development, LLC 188
Not applicableStudy completedNCT02623621
What this trial is testing

Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 103
Early research (Phase 1)Looking for participantsNCT06625593
What this trial is testing

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 168
Early research (Phase 1)WithdrawnNCT01941849
What this trial is testing

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

Who this might be right for
PhaeochromocytomaParaganglioma
University College, London
Next Page